Does PALBOCICLIB Cause Epistaxis? 1,280 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,280 reports of Epistaxis have been filed in association with PALBOCICLIB (Ibrance). This represents 1.4% of all adverse event reports for PALBOCICLIB.
1,280
Reports of Epistaxis with PALBOCICLIB
1.4%
of all PALBOCICLIB reports
50
Deaths
201
Hospitalizations
How Dangerous Is Epistaxis From PALBOCICLIB?
Of the 1,280 reports, 50 (3.9%) resulted in death, 201 (15.7%) required hospitalization, and 1 (0.1%) were considered life-threatening.
Is Epistaxis Listed in the Official Label?
Yes, Epistaxis is listed as a known adverse reaction in the official FDA drug label for PALBOCICLIB.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Epistaxis?
RIVAROXABAN (5,629)
ASPIRIN (3,214)
APIXABAN (2,831)
FLUTICASONE (1,745)
TREPROSTINIL (1,726)
CLOPIDOGREL BISULFATE (1,560)
BEVACIZUMAB (1,542)
WARFARIN (1,498)
ADALIMUMAB (1,243)
METHOTREXATE (1,108)
Which PALBOCICLIB Alternatives Have Lower Epistaxis Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID